They reported a significant median 1.34-fold increase in anti-CD74 antibody levels post-ICI treatment in patients with CIP, whereas no significant changes were detected in a comparison group of 20 patients without pneumonitis, suggesting a pathogenic role for CD74 autoantibodies in the development of pneumonitis (78). This evidence concerns the gene CD74 and hereditary sensory and autonomic neuropathy.